ALB and cancer: Nima Beheshtizadeh and research collaborators comprehensively analyzed the transformative potential of docetaxel-loaded nanoplatforms in oncology, establishing that albumin-based delivery systems represent a paradigm shift in chemotherapeutic efficacy for cancer treatment.